New York, July 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Next Move Strategy Consulting, the global pharmaceutical isolator market accrued USD 1.62 billion in 2021, and is estimated to reach USD 4.17 billion by 2030, registering a CAGR of 11.1% from 2022 to 2030. Through an extensive research methodology and collection of data from the trusted sources, the report presents a detailed analysis of current market size, drivers & opportunities, estimations regarding performance of key segments and sub-segments in different regions and countries, and leading players.
Wrapping up the comprehensive analysis and valuable insights in 290 pages, supported by 234 tables and 227 figures, the research aims to help market players, angel investors, new entrants, and shareholders. It highlights the overall scenario of the global pharmaceutical isolator industry and assists in making necessary decisions about the future.
Request a free sample: https://www.nextmsc.com/pharmaceutical-isolator-market/request-sample
| Report Coverage | Details |
| Forecast Period | 2022–2030 |
| Base Year | 2021 |
| Market Size in 2021 | USD 1.62 billion |
| Market Size in 2030 | USD 4.17 billion |
| CAGR | 11.1% |
| No. of Pages | 290 |
| Tables | 234 |
| Figures | 227 |
| Segments covered | Type, Pressure, Application, End User, and Geography. |
| Drivers | Surge in prevalence of cancer & increase in demand for biologic products |
| Low operational costs | |
| Opportunities | Increase in need for strategic alliances between the mid- and small-sized pharmaceutical… |
